TCO-PEG3-amide-C3-triethoxysilane PEG2-C2-amine Etripamil (MSP-2017) is a short-acting

Etripamil (MSP-2017) is a short-acting L-type calcium-channel antagonist

and last for 4–6 hours

and play a crucial role in endothelial cell adhesion and migration

ML241 is still in the preclinical development stage

and its combination activity with chemotherapies in patient biopsy derived small cell lung cancer (SCLC) xenograft models

TCO-PEG3-amide-C3-triethoxysilane PEG2-C2-amine Etripamil (MSP-2017) is a short-actingTCO PEG3 amide C3 triethoxysilane is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 2250217 32 2 Molecular Weight: 576. 80 Formula: C27H52N2O9Si Chemical Name: cyclooct 4 en 1 yl N (2 {2 [2 (2 {[3 (triethoxysilyl)propyl]carbamoyl}ethoxy)ethoxy]ethoxy}ethyl)carbamate Smiles: CCO[Si](CCCNC(=O)CCOCCOCCOCCNC(=O)OC1CCC=CCCC1)(OCC)OCC c: 28 InChiKey: ZXQAFZQBZKLJGI FPLPWBNLSA N InChi: InChI=1S